Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares Bitcoin ETF (BITO) vs Johnson & Johnson (JNJ) Price & Performance

ProShares Bitcoin ETFTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

ProShares Bitcoin ETF vs Johnson & Johnson — how do they compare? ProShares Bitcoin ETF trades at $8.57, while Johnson & Johnson trades at $260.69 (market cap $626.09B). The key difference: Johnson & Johnson pays a 2.06% dividend while ProShares Bitcoin ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, ProShares Bitcoin ETF nearer its low. Which is the better fit depends on your goals.

BITOJNJ
Sector
Crypto-linkedHealth
52-Week High
$22.27$267.24
52-Week Low
$7.98$172.78
Market Cap
$626.09B
Volume
6,156,228
Enterprise Value
$654.37B
Dividend Yield
2.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ProShares Bitcoin ETF

BITO trades at $8.64 with no recent price movement, showing technical bearish signals from moving averages while oscillators remain neutral. The ETF faces headwinds as recent analysis highlights underperformance compared to spot Bitcoin ETFs, with Seeking Alpha maintaining a Sell rating for retail investors. Dividend distributions of $0.01 per share provide modest income but haven't offset significant price declines over the past year.

The outlook remains challenging with institutional sentiment turning cautious amid crypto market volatility. Key risks include high fee structures, competitive pressure from newer spot Bitcoin ETFs, and correlation breakdowns with traditional risk assets. Analyst consensus leans bearish given the fund's structural disadvantages and ongoing crypto winter conditions.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.

Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ProShares Bitcoin ETF

BITO offers exposure to Bitcoin returns primarily through Bitcoin futures contracts. It provides a regulated way for investors to trade Bitcoin performance within a traditional brokerage account without direct ownership.

Read more on BITO

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ